PCN Insights, News, Videos, and More
News
10/01/2021
Mental health providers equipped to provide telemental health will be better positioned to cope with future pandemics and public health crises, new study concludes.
Mental health providers equipped to provide telemental health will be better positioned to cope with future pandemics and public health crises, new study concludes.
Mental health providers equipped...
10/01/2021
Psych Congress Network
Podcasts
09/30/2021
In his live Table Talk session at the Sana Symposium, Rick Doblin, PhD, discusses measuring cognition during psychedelic-assisted therapy clinical trials.
In his live Table Talk session at the Sana Symposium, Rick Doblin, PhD, discusses measuring cognition during psychedelic-assisted therapy clinical trials.
In his live Table Talk session...
09/30/2021
Psych Congress Network
Podcasts
09/30/2021
In his live Table Talk session at the Sana Symposium, Rick Doblin, PhD, Founder and Executive Director, Multidisciplinary Association for Psychedelic Studies (MAPS), answers the question of whether or not hallucinations automatically indicate...
In his live Table Talk session at the Sana Symposium, Rick Doblin, PhD, Founder and Executive Director, Multidisciplinary Association for Psychedelic Studies (MAPS), answers the question of whether or not hallucinations automatically indicate...
In his live Table Talk session...
09/30/2021
Psych Congress Network
News
09/29/2021
Heather Flint, Senior Digital Managing Editor
Psychedelic-assisted therapy is an emerging treatment that is gaining traction and attention.
Psychedelic-assisted therapy is an emerging treatment that is gaining traction and attention.
Psychedelic-assisted therapy is...
09/29/2021
Psych Congress Network
Videos
09/29/2021
Dr Citrome discusses the possible outcomes for Roger and Frank, 2 patients with schizophrenia in part 1 of this 'How I Treat' series.
Dr Citrome discusses the possible outcomes for Roger and Frank, 2 patients with schizophrenia in part 1 of this 'How I Treat' series.
Dr Citrome discusses the...
09/29/2021
Psych Congress Network
News
09/28/2021
Researchers have developed a blood test composed of RNA biomarkers to discern a patient’s depression severity, the risk of future severe depression and bipolar disorder, and informs personalized medication choices for patients.
Researchers have developed a blood test composed of RNA biomarkers to discern a patient’s depression severity, the risk of future severe depression and bipolar disorder, and informs personalized medication choices for patients.
Researchers have developed a...
09/28/2021
Psych Congress Network
News
09/28/2021
Better physiological recovery during sleep was associated with better overall diet quality, higher intake of fiber, stronger dietary self-control, and lower alcohol consumption in stressed working-age adults with obesity.
Better physiological recovery during sleep was associated with better overall diet quality, higher intake of fiber, stronger dietary self-control, and lower alcohol consumption in stressed working-age adults with obesity.
Better physiological recovery...
09/28/2021
Psych Congress Network
News
09/28/2021
Heather Flint, Senior Digital Managing Editor
The US FDA has approved Janssen Pharmaceutical’s INVEGA HAFYERA (6-month paliperidone palmitate), a long-acting, atypical antipsychotic for adults with schizophrenia.
The US FDA has approved Janssen Pharmaceutical’s INVEGA HAFYERA (6-month paliperidone palmitate), a long-acting, atypical antipsychotic for adults with schizophrenia.
The US FDA has approved Janssen...
09/28/2021
Psych Congress Network
Videos
09/28/2021
Ann Childress, PhD, discusses the next steps in the treatment of 3-year-old female who presented for an evaluation of anxiety and depression.
Ann Childress, PhD, discusses the next steps in the treatment of 3-year-old female who presented for an evaluation of anxiety and depression.
Ann Childress, PhD, discusses...
09/28/2021
Psych Congress Network
News
09/27/2021
Lumateperone can safely improve symptoms for patients with bipolar I or bipolar II disorder experiencing major depressive episodes, according to new research published in the American Journal of Psychiatry.
Lumateperone can safely improve symptoms for patients with bipolar I or bipolar II disorder experiencing major depressive episodes, according to new research published in the American Journal of Psychiatry.
Lumateperone can safely improve...
09/27/2021
Psych Congress Network
